TalarAVN: Talar Avascular Necrosis: Surgical Angiogenesis vs. Core Decompression
Study Details
Study Description
Brief Summary
The purpose of this study is to determine if surgical angiogenesis performed in talar avascular necrosis by free microvascular bone grafts from the femoral condyle is a superior technique compared to core decompression and nonvascularized osseous autografts.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
The aim of this prospective randomized clinical trial is the comparison of two surgical treatment options for talar avascular necrosis (analogical to Ficat and Arlet stage II and III). The randomized study design allows direct comparability of the outcome after either core decompression and nonvascularized osseous autografting from the iliac crest or core decompression and osseous autografting with a free microvascular medial femoral condyle.
Talar avascular necrosis is caused by osseous malperfusion leading to malnutrition and destruction of the talar bone. The extend of this malperfusion is variable and can be categorized in 4 stages. The osseous defects can remain without consequences (stage I) or lead to irreversible talar destruction. The current treatment option for stage II and III is the core decompression followed by osseous auto grafting from the iliac crest. Reducing the intraosseal pressure and filling the drill holes with the bone graft can lead to reperfusion of the talus.
A new technique is to fill the drill hole with a vascularized bone graft from the medial femoral condyle, using microvascular anastomosis. This procedure has already been approved for the treatment of avascular necrosis and malperfusion of the carpus (lunate and scaphoid) as well as the femoral head.
Patients are examined preoperative as well as 3, 6 and 12 month after operation, documenting the active range of motion and pain sensation while resting and on activity. Well established scores like the AOFAS Ankle-Hindfoot Score and the Lower Extremity Functional Scale are used to get subjective and objective informations about patients' daily life and postoperative satisfaction. X-Rays are taken at the same stages. MRIs of the ankle joint with contrast agent are performed before as well as 6 and 12 months after surgery.
Statistical analysis is performed using the Statistical Package for the Social Sciences (SPSS). The Study protocol has been approved by the Ethics Commission of Rheinland-Pfalz. Interventions are done according to the declaration of Helsinki.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: medial femoral condyle Patients in this arm receive core decompression followed by free vascularized medial femoral condyle graft |
Procedure: core decompression
retrograd drilling of the avascular talar necrosis, followed by osseous autograft
|
Active Comparator: core decompression Patients in this arm receive core decompression followed by osseous autograft from the iliac crest |
Procedure: core decompression
retrograd drilling of the avascular talar necrosis, followed by osseous autograft
|
Outcome Measures
Primary Outcome Measures
- Pain reduction [3, 6, 12 months post operation]
Secondary Outcome Measures
- Lower Extremity Functional Scale [pre operation; 3, 6, 12 month post operation]
- Revascularization (Association International de Recherche sur la Circulation Osseuse-Criteria) [6 and 12 month postoperative]
- American Orthopaedic Foot and Ankle Society- Ankle and Hindfoot Score [pre operation; 3, 6, 12 month post operation]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Avascular talar necrosis stage 2 and 3 (Ficat and Arlet)
-
signed patient consent form
Exclusion Criteria:
-
steroid or chemo therapy
-
participation in a different study
-
pregnancy
-
peripheral artery occlusive disease stage 3 and 4
-
avascular talar necrosis stage 1
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | BG Trauma Center Ludwigshafen | Ludwigshafen | Rheinland-Pfalz | Germany | 67071 |
Sponsors and Collaborators
- BG Trauma Center Ludwigshafen
Investigators
- Study Chair: Ulrich Kneser, Phd, MD, BG Trauma Center Ludwigshafen
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- BGU - 01/14